Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEN
2276
DELISTED
Denbury Inc.
DEN
| $2.72M | ﹤0.01% |
38,697
-28,417
| -42% | -$1.96M |
|
2277
TG Therapeutics
TGTX
$7.07B
| $2.72M | ﹤0.01% |
81,664
-33,757
| -29% | -$1.04M |
|
|
VRNA
2278
DELISTED
Verona Pharma
VRNA
| $2.71M | ﹤0.01% |
+495,446
| New | +$2.88M |
|
2279
Vanguard Morningstar Large-Cap ETF
VV
$53.2B
| $2.71M | ﹤0.01% |
13,488
-4,663
| -26% | -$964K |
|
2280
Under Armour Class C
UA
$2.83B
| $2.71M | ﹤0.01% |
154,629
-1,232,975
| -89% | -$23.6M |
|
2281
Insmed
INSM
$21.3B
| $2.71M | ﹤0.01% |
98,332
-72,497
| -42% | -$1.9M |
|
2282
PUT
Paychex
PAYX
$41.9B
| $2.7M | ﹤0.01% |
24,000
| – | – |
|
2283
Telkom Indonesia
TLK
$15B
| $2.69M | ﹤0.01% |
105,842
-73,783
| -41% | -$1.7M |
|
2284
Ultragenyx Pharmaceutical
RARE
$2.46B
| $2.68M | ﹤0.01% |
29,749
-25,416
| -46% | -$2.3M |
|
2285
PUT
Invesco Mortgage Capital
IVR
$757M
| $2.68M | ﹤0.01% |
85,000
| – | – |
|
|
SRNE
2286
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.68M | ﹤0.01% |
350,959
-218,421
| -38% | -$1.85M |
|
2287
Nice
NICE
$5.9B
| $2.68M | ﹤0.01% |
9,428
-3,739
| -28% | -$1.04M |
|
2288
3D Systems Corp
DDD
$462M
| $2.67M | ﹤0.01% |
96,908
-4,743
| -5% | -$140K |
|
2289
Gevo
GEVO
$355M
| $2.67M | ﹤0.01% |
402,315
-315,103
| -44% | -$1.95M |
|
2290
Inovio Pharmaceuticals
INO
$57.3M
| $2.67M | ﹤0.01% |
31,027
-20,627
| -40% | -$2.07M |
|
2291
MaxLinear
MXL
$6.09B
| $2.66M | ﹤0.01% |
54,095
+6,359
| +13% | +$308K |
|
2292
CALL
Tenet Healthcare
THC
$20.1B
| $2.66M | ﹤0.01% |
+40,000
| New | +$2.84M |
|
|
ILPT
2293
Industrial Logistics Properties Trust
ILPT
$584M
| $2.65M | ﹤0.01% |
104,470
-24,255
| -19% | -$648K |
|
2294
Kirby Corp
KEX
$6.98B
| $2.65M | ﹤0.01% |
55,353
-10,463
| -16% | -$580K |
|
2295
iShares Core S&P US Value ETF
IUSV
$27.3B
| $2.65M | ﹤0.01% |
37,411
-13,790
| -27% | -$1M |
|
2296
Virtu Financial
VIRT
$5.12B
| $2.65M | ﹤0.01% |
108,531
-109,413
| -50% | -$2.78M |
|
2297
Sensient Technologies
SXT
$5.37B
| $2.64M | ﹤0.01% |
28,996
-4,042
| -12% | -$354K |
|
2298
Viavi Solutions
VIAV
$9.31B
| $2.63M | ﹤0.01% |
167,377
-27,198
| -14% | -$446K |
|
2299
Jack in the Box
JACK
$324M
| $2.63M | ﹤0.01% |
27,073
+5,637
| +26% | +$588K |
|
2300
PUT
Kroger
KR
$35.7B
| $2.63M | ﹤0.01% |
+65,000
| New | +$2.73M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.